Seminars in Nuclear Medicine
Volume 34, Issue 1, Supplement , Pages 20-23, January 2004

Radiation safety considerations with yttrium 90 ibritumomab tiuxetan (Zevalin)

  • Xiaowei Zhu

      Affiliations

    • Department of Radiology, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA
    • *Address reprint requests to Xiaowei Zhu, MS, DABMP, Department of Radiology, The Children’s Hospital of Philadelphia, 34th St and Civic Center Blvd, Philadelphia, PA 19104-4399, USA
    • 1Ms Zhu has received research grant support from Biogen Idec Inc.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0001-2998(03)00082-5

doi:10.1053/j.semnuclmed.2003.11.005

Seminars in Nuclear Medicine
Volume 34, Issue 1, Supplement , Pages 20-23, January 2004

Article Tools

* Image Usage & Resolution